FDA Recalls Accula SARS-CoV-2 Test for False Positive Risk
Mesa Biotech is recalling approximately 6,162 units of the Accula SARS-CoV-2 Test due to an increased risk of false positive results, which could delay correct diagnosis and treatment.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum severity score of 4 per the rubric. Although no illnesses or injuries are reported, the potential for false positive test results in a diagnostic device represents a significant defect affecting diagnostic accuracy and patient care.
Plain-English summary
The Accula SARS-CoV-2 Test (REF: COV4100), manufactured by Mesa Biotech, Inc., is being recalled due to an increased potential for false positive results. Approximately 6,162 units were distributed across the United States in multiple states.
False positive test results occur when a test incorrectly indicates the presence of an infection that is not actually present. This increases the risk that patients could be incorrectly diagnosed and may experience delays in receiving the correct diagnosis and treatment.
The FDA classified this as a Class I recall.
The recalled product
- Product
- Accula SARS-CoV-2 Test, REF: COV4100
- Manufacturer
- MESA BIOTECH, INC
- Category
- Medical Device — Diagnostic Test
- Hazard
- false-positive
- diagnostic-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- UDI/DI: B540COV41000
- P22006-026
- P22010-021
- P22024-023
- P22024-030
- P22026-006
- P22026-012
- P22026-016
- P22010-001
- P22010-030
- P22024-026
- P22024-032
- P22026-007
- P22026-013
- P22026-017
- P22010-017
- P22010-032
- P22024-027
- P22026-002
- P22026-008
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03